Biotechnology Value Fund

Biotechnology Value Fund covers 9 companies with a founder-verified check from Biotechnology Value Fund, concentrated in Biotech. Round sizes are not disclosed for these companies, so this report lists the verified positions rather than dollar totals.

• Verified portfolio companies: 9
• Sector mix: Biotech 9
• Headquarters mix: Boston 2 · Waltham 1 · San Diego 1 · Needham 1

Biotechnology Value Fund — verified positions

• Antares Therapeutics
• Crescent Biopharma
• ImageneBio
• Verastem Oncology
• Third Arc Bio
• Ambrosia Biosciences
• Bambusa Therapeutics
• Merida Biosciences
• Numab

Biotechnology Value Fund — related firms and companies (44)

• Kymera Therapeutics
• Biotechnology Value Fund portfolio companies 2026
• Investors like Biotechnology Value Fund
• Founders backed by Biotechnology Value Fund
• Investors like Google Ventures
• Investors like Bain Capital
• Investors like Venrock
• Investors like Accomplice
• Investors like F-Prime
• Investors like Capital One Ventures
• Investors like Coinbase
• Investors like Founders Fund
• Investors like Greylock
• Investors like SOSV
• Investors like Atlas Venture
• Investors like FirstMark
• Investors like GSR Ventures
• Investors like HSG
• Investors like Expansion Venture Capital
• Investors like Khosla Ventures
• Investors like True Ventures
• Investors like Tiger Global Management
• Investors like Floodgate
• Investors like Torch Capital
• Investors like Motivate Venture Capital
• Investors like Irving Investors
• Investors like Forerunner
• Investors like Bessemer Venture Partners
• Investors like CRV
• Investors like Greycroft
• Firms like GV
• Investors like Western Technology Investment
• Investors like Peak XV Partners
• Investors like Lightbank
• Investors like GIC
• Investors like Plug and Play
• Investors like Draper Associates
• Investors like Wellington Management
• Investors like Maveron
• Investors like ACME Capital
• Investors like Acre Venture Partners
• Investors like Maven Ventures
• Investors like Oak HC/FT
• Investors like BoxGroup

Biotechnology Value Fund alternatives · All research reports